No Detail Found!

Skin thickness and internal organ involvement in patients of systemic sclerosis

Author(s)
Fareheen Ashfaq Department of Dermatology, Dow University of Health Sciences, Karachi, Pakistan
Humaira Talat Department of Dermatology, Dow University of Health Sciences, Karachi, Pakistan
Faisal Ahmed Department of Cardiology, Civil Hospital, Dow University of Health Sciences, Karachi, Pakistan
Maria Mansoor Department of Dermatology, Dow University of Health Sciences, Karachi, Pakistan
Reema Mirza Department of Dermatology, Dow University of Health Sciences, Karachi, Pakistan
Erum Ashraf Institute of Skin Disease, Dow University of Health Sciences, Karachi, Pakistan
Abstract
Objective: To elucidate the current magnitude of the internal organ/s involvement in patients of systemic sclerosis concerning their Modified Rondnan skin score (MRSS). Methods: A total of 52 patients were included. Skin thickness was calculated by MRSS, and internal organ/s by history, examination, and investigations like serum creatinine, transthoracic echocardiography, HRCT and PFTs. Relation of skin thickness and internal organ involvement was studied. Data ware analyzed by SPSS version 24.0. Results: Mean MRSS score was 19.4±10.53, female predominance (88.4%) and mean duration of 6.3±6.2 years The visceral involvement in patients with MRSS >20 showed greater visceral involvement. Isolated pulmonary involvement was recorded in 67.3% followed by pulmo-renal 11.5%, Pulmo-cardiac in 5.7% and pulmo-renal-cardiac in 9.6% of patients (p=0.001). Conclusion: Our study showed the predominant involvement of pulmonary organs and the relation of MRSS with visceral involvement. The study emphasized the significance of MRSS as a non-invasive clinical tool for identifying high-risk patients at initial presentation.
Publication Details
Page(s) 1-4
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 49, Issue: 2, Year: 2024

Request the full text from PASTIC

Keywords
pulmonary function tests, Interstitial lung disease, Systemic Sclerosis., High-resolution contrast tomography, Modified Rodnan Skin Score
References
Adigun R,Goyal A,Hariz A. Systemic,Sclerosis A. Systemic,Island (FL): StatPearls Publishing A. Systemic . .. [Updated 2022 May, 8 : .
Asano Y. .2020 .The Pathogenesis of Systemic Sclerosis: An Understanding Based on a Common Pathologic Cascade across Multiple Organs and Additional Organ-Specific Pathologies. J Clin Med, 9(9) : 2687.
Clements PJ,Furst DE,Campion DS .1978 .Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations. Arthritis Rheum, 21(1) : 62-71.
Herrick AL,Assassi S,Denton CP .2022 .Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need. Nat Rev Rheumatol, 18(5) : 276-285.
Clements P,Lachenbruch P,Siebold J .1995 .Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol, 22(7) : 1281-1285.
Jaafar S,Lescoat A,Huang S. .2021 .Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort. Arthritis Res Ther, 23(1) : 170-5.
Steen VD,Medsger TA .2000 .Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum, 43(11) : 2437-2444.
Clements PJ,Hurwitz EL,Wong WK .2000 .Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum, 43(11) : 2445-2454.
Shand L,Lunt M,Nihtyanova S M .2007 .Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model. Arthritis Rheum, 56(7) : 2422-2431.
Bairkdar M,Rossides M,Westerlind H M .2021 .Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis. Rheumatology (Oxford), 60(7) : 3121-3133.
Adigun R,Goyal A,Hariz A. Systemic,Sclerosis A. Systemic .2022 .. StatPearls Publishing; May 8, : .
Yang N,Knipe H,Hailu Z. Scleroderma H .2024 .(gastrointestinal manifestations). Reference article, Radiopaedia.org (Accessed on 02 Mar, : .
Jerjen R,Nikpour M,Krieg T. .2022 .Systemic sclerosis in adults. Part II: management and therapeutics. J Am Acad Dermatol, 87(5) : 957-978.
Silman AJ,Hochberg MC .1993 .Cooper C. Epidemiology of the Rheu-matic Diseases. , : 192.
Lawrence RC,Helmick CG,Arnett FC .1998 .Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum, 41(5) : 778-799.
Khanna D,Furst DE,Clements PJ .2017 .Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J Scleroderma Relat Disord, 2(1) : 11-18.
Caron M,Hoa S,Hudson M,Schwartzman K,Steele R K .2018 .Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease. Eur Respir Rev, 27(148) : 170102.
Ali Malik AM,Mahmud TH,Rasheed A .2021 .Modified Rodnan Skin Score and its Association with Extent of Lung Damage in Systemic Sclerosis Patients. Ann King Edward Med Univ, 27(2) : 204-9.
Matsuda KM,Yoshizaki A,Kuzumi A .2019 .Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study. Arthritis Res Ther, 21(1) : 129-32.
Bhakuni DS,Vasdev V,Garg MK .2012 .Nailfold capillaroscopy by digital microscope in an Indian population with systemic sclerosis. Int J Rheum Dis, 15(1) : 95-101.
Giovanni Barisione .2021 .Pulmonary function tests in systemic sclerosis-associated interstitial lung disease: new directions and future prospects. Curr Opin Physiol, 22 : 100442.
0

Citations

0

Downloads

32

Views